DZ Bank
WST icon

DZ Bank’s West Pharmaceutical WST Stock Holding History

DZ Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
27,963
+27,520
+6,212% +$8.41M 0.01% 395
2026
Q1 		$111K Hold
443
– – ﹤0.01% 930
2025
Q4 		$122K Buy
+443
New +$121K ﹤0.01% 908
2025
Q2 		– Sell
-2,361
Closed -$529K – 1060
2025
Q1 		$529K Buy
2,361
+500
+27% +$138K ﹤0.01% 751
2024
Q4 		$610K Sell
1,861
-3,774
-67% -$1.19M ﹤0.01% 717
2024
Q3 		$1.69M Sell
5,635
-24,781
-81% -$7.59M ﹤0.01% 595
2024
Q2 		$10M Sell
30,416
-30,454
-50% -$10.8M 0.01% 353
2024
Q1 		$24.1M Buy
60,870
+57,811
+1,890% +$21.4M 0.03% 239
2023
Q4 		$1.08M Sell
3,059
-4,748
-61% -$1.68M ﹤0.01% 636
2023
Q3 		$2.93M Buy
7,807
+155
+2% +$59.9K ﹤0.01% 514
2023
Q2 		$2.93M Buy
7,652
+4,798
+168% +$1.71M ﹤0.01% 532
2023
Q1 		$989K Buy
+2,854
New +$834K ﹤0.01% 669
2022
Q4 		– Sell
-52
Closed -$12.8K – 1102
2022
Q3 		$12.8K Sell
52
-2,952
-98% -$899K ﹤0.01% 998
2022
Q2 		$908K Buy
+3,004
New +$977K ﹤0.01% 724
2021
Q3 		– Sell
-2,434
Closed -$874K – 1008
2021
Q2 		$874K Sell
2,434
-26,952
-92% -$8.9M ﹤0.01% 705
2021
Q1 		$8.28M Buy
29,386
+27,644
+1,587% +$7.91M 0.02% 368
2020
Q4 		$494K Sell
1,742
-2,758
-61% -$774K ﹤0.01% 687
2020
Q3 		$1.24M Buy
4,500
+4,016
+830% +$1.06M ﹤0.01% 527
2020
Q2 		$110K Buy
+484
New +$95.1K ﹤0.01% 716
2019
Q3 		– Sell
-53,667
Closed -$6.72M – 810
2019
Q2 		$6.72M Sell
53,667
-29,908
-36% -$3.53M 0.02% 328
2019
Q1 		$9.21M Buy
83,575
+4,965
+6% +$516K 0.03% 271
2018
Q4 		$7.56M Sell
78,610
-10,611
-12% -$1.15M 0.03% 280
2018
Q3 		$11M Buy
89,221
+5,212
+6% +$584K 0.04% 246
2018
Q2 		$8.34M Buy
84,009
+64,000
+320% +$5.89M 0.03% 302
2018
Q1 		$1.77M Buy
20,009
+17,855
+829% +$1.67M 0.01% 568
2017
Q4 		$212K Buy
+2,154
New +$211K ﹤0.01% 708

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DZ Bank's WST Position: Q2 2026 in Review

DZ Bank increased its West Pharmaceutical (WST) stake by 6,212% in Q2 2026, buying an estimated $8.41M and bringing the position to 27,963 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #395.

DZ Bank first reported a position in WST in Q4 2017 and has held it in 26 quarters since. The position peaked at $24.1M in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • DZ Bank held 27,963 shares of West Pharmaceutical worth $10M as of Q2 2026.
  • DZ Bank bought 27,520 West Pharmaceutical shares in Q2 2026, an estimated $8.41M.
  • West Pharmaceutical made up 0.01% of DZ Bank's portfolio in Q2 2026, its #395 holding.
  • DZ Bank first reported a position in West Pharmaceutical in Q4 2017 and has held it in 26 quarters since.
  • DZ Bank's West Pharmaceutical position peaked at $24.1M in Q1 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.